Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: A randomized, double-blind study

Human Psychopharmacology

Volumn 23, Issue 4, 2008, Pages 313-319

  Altintoprak, A Ender ^a   Zorlu, Nabi ^b   Coskunol, Hakan ^a   Akdeniz, Fisun ^a   Kitapcioglu, Gul ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Alcohol dependence; Amitriptyline; Co morbidity; Depressive disorder; Mirtazapine

Indexed keywords

AMITRIPTYLINE; DIAZEPAM; MIRTAZAPINE; VITAMIN B COMPLEX;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DETOXIFICATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; LIBIDO; MALE; POSITIONAL DIZZINESS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCREENING TEST; SEDATION; SIDE EFFECT; STATE TRAIT ANXIETY INVENTORY; TREMOR; XEROSTOMIA;

ADULT; ALCOHOLISM; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; QUESTIONNAIRES;

EID: 47249110793     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.935     Document Type: Article

References (36)

1. Ables AZ, Baughman OL 3rd. 2003. Antidepressants: update on new agents and indications. Am Fam Physician 67: 547-554.
2. Akdemir A, Turkcapar MH, Orsel SD, Demirergi N, Daǧ I, Ozbay HM. 2001. Reliability and validity of the Turkish version of Hamilton Depression Rating Scale. Compr Psychiatry 42: 161-165.
3. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Press: Washington DC.
4. Bagby RM, Ryder AG, Cristi C. 2002. Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci 27: 250-257.
5. Breyer-Pfaff U. 2004. The metabolic late of amitriptyline, nortriptyline and amitriptylinoxide in man. Drug Metab Rev 36: 723-746.
6. Brown SA, Irwin M, Schuckit MA. 1991. Changes in anxiety among abstinent male alcoholics. J Stud Alcohol 52: 55-61.
7. Brown SA, Schuckit MA. 1988. Changes in depression among abstinent alcoholics. J Stud Alcohol 49: 412-417.
8. Cornelius JR, Salloum IM, Ehler JG, et al. 1997. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 54: 700-705.
9. Coskunol H, Bagdiken I, Sorias S, Saygili R. 1995. Michigan Alkolizm Tarama Testinin Gecerliligi. Ege Tip Dergisi 34: 15-18.
10. Crockford DN, White WD. 2005. Mirtazapine for alcohol dependence: a case report. J Clin Psychiatry 66: 540.
11. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-562.
12. Helzer JE, Przybeck TR. 1988. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol49: 219-224.
13. Kasper S, Pletan Y, Solles A, Tournoux A. 1996. Comparative studies with milnacipran and tricylic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. Int Clin Psychopharmacol 11 (suppl 4): 35-39.
14. Kasper S, Zivkov M, Roes KC, Pols AG. 1997. Pharmacological treatment of severely depressed patients: a meta-analysis comparing efficacy of mirtazapine and amitriptyline. Eur Neuropsychopharm 7: 115-124.
15. Kosten TR, O'Conner PG. 2003. Management of drug and alcohol withdrawal. N Eng J Med 348: 1786-1795.
16. LeMarquand D, Pihl RO, Benkelfat C. 1994. Serotonin and alcohol intake, abuse and dependence: clinical evidence. Biol Psychiatry 36: 395-42.
17. Liappas J, Paparrigopoulos T, Malitas P, Tzavellas E, Christodoulou G. 2004. Mirtazapine improves alcohol detoxification. J Psychopharmacol 18: 88-93.
18. Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G. 2002. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend 68: 215-220.
19. Liappas J, Paparrigopoulos T, Tzavellas E, Rabavilas A. 2005. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. Prog Neuropsychopharmacol 29: 55-60.
20. Lingjaerde O, Ahlfors UG, Bech P, et al. 1987. The UKU Side Effect Rating Scale. Acta Psychiatr Scand 76(suppl 334): 1-96.
21. Loo H, Malka R, Defrance R, et al. 1988. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 19: 79-85.
22. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. 1996. A double blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275: 761-767.
23. McGrath PJ, Nunes EV, Stewart JW, et al. 1996. Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial. Arch Gen Psychiatry 53: 232-240.
24. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. 2003. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 23: 553-562.
25. Nunes EV, Levin FR. 2004. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 291: 1887-1896.
26. Nunes EV, McGrath PJ, Quitkin FM, et al. 1993. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry 150: 963-965.
27. Oner N, LeCompte A. 1985. Durumluk-Sürekli Kaygi Envanteri El Kitabi. İkinci Baski. Boǧaziçi Üniversitesi Matbaasi, İstanbul.
28. Puzantian T. 1998. Mirtazapine, an antidepressant. Am J Health Syst Pharm 55: 44-49.
29. Roy-Byrne PP, Pages KP, Russo JE, et al. 2000. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 20: 129-136.
30. Schuckit MA. 1986. Genetic and clinical implications of alcoholism and affective disorders. Am J Psychiatry 143: 140-147.
31. Schuckit MA. 1996. Recent developments in the pharmacotherapy of alcohol dependence. J Consult Clin Psychol 64: 669-676.
32. Selzer M. 1971. The Michigan Alcoholism Screening Test (MAST): the quest for a new diagnostic instrument. Am J Psychiatry 127: 1653-1658.
33. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA. 1983. State-Trait Anxiety Inventory for Adults. Mind Garden: Palo Alto, CA.
34. Tabakoff B, Hoffman PL. 1991. Neurochemical effects of alcohol. In Clinical Textbook of Addictive Disorders, Frances RJ, Miller SI (eds). Guilford Press: New York; 501-525.
35. Torrens M, Fonseca F, Mateu G, Farre M. 2005. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 78: 1-22.
36. Yoon SJ, Pae CU, Kim DJ, et al. 2006. Mirtazapine for patients with alcohol dependence and comorbid depressive disorder: a multi-centre, open label study. Prog Neuropsychopharmacol 30: 1196-1201.